Each sachet (5.6 g) contains: Sodium citrate BP 4.0 g (Contains 939 mg of sodium).
Excipients/Inactive Ingredients: Sucrose, sodium saccharine, cranberry flavor 191121.
Pharmacotherapeutic group: Systemic alkalinizing substance. ATC code: B05CB02.
Pharmacology: Pharmacodynamics: Sodium Citrate is metabolized into bicarbonate, which facilitates regression dysuria, that is observed in cystitis, causing a reduce of urinary acidity causing alkalinization.
Kataria granules are indicated for: Relief of the symptoms of UTI (burning micturition & cystitis in women) in adults.
Buffering and neutralizing gastric hydrochloric acid quickly and effectively.
Those conditions where long term maintenance of alkaline urine is desirable and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated.
Pour the content of sachet into the glass of water. Stir till formation of clear solution.
1. For short term usage in burning micturition and cystitis in women: Adult: The contents of one sachet are dissolved in a glass of water (around 250 ml), it is taken three times a day for 2-3 days or as directed by a physician.
2. For long term usage in systemic alkalization: The contents of half sachet are dissolved in glass of water (around 250 ml), it is taken three times a day for 2-3 days or as directed by a physician.
Mode of Administration: Oral.
In the unlikely event of overdosage occurring with this product, treatment should be symptomatic.
Excessive administration of sodium citrate may cause gastrointestinal discomfort and diarrhoea. Excessive doses of sodium salts may lead to sodium overloading and hyperosmolality. Excessive administration of bicarbonate may lead to hypokalaemia and metabolic alkalosis, especially in patients with impaired renal function. Treatment is symptomatic and consists of appropriate correction of fluid and electrolyte balance.
Hypersensitivity to sodium citrate and other components of this medicine.
It is contraindicated to patients with diabetes, heart disease, arterial hypertension, renal disease or patients who are on a low salt diet.
If symptoms persist after two days of treatment it is necessary to consult a doctor.
Do not exceed the stated dose.
This medicine contains 939 mg sodium (main component of cooking/table salt) in each sachet. This is equivalent to 47% of the recommended maximum daily dietary intake of sodium for an adult.
Effects on Ability to Drive and Use Machines: None stated.
It is contraindicated during pregnancy and lactation.
Single case of skin rash and abdominal pain has been reported.
Adverse Drug Reaction:
Inform doctors about unexpected reactions after using drugs.
Sodium containing preparations should be avoided by patients on lithium because sodium is preferentially absorbed by the kidney resulting in increased lithium excretion and reduced plasma levels.
Urinary alkalinizers should not be used with hexamine because it is only effective in acid urine.
The effects of a number of drugs may be reduced or increased by the alkalization of the urine and reduction in gastric pH brought about by the active ingredients in the product.
Store below 30°C.
Shelf-Life: 36 months.
B05CB02 - sodium citrate ; Belongs to the class of salt solutions used as irrigating solutions.
Granules for oral soln (sachet) (white-off white color, free flowing, flavored) 4 g/5.6 g x 6's.